MAPT and neurodegenerative disease: Although the developments in induced pluripotent stem cell (iPSC) technology have facilitated the investigation of phenotypes of neurodegenerative diseases including FTLD-Tau patient neural cells in vitro16, 17, 18, 19, the mechanism involved in neurodegeneration in FTLD-Tau patient neurons is still unclear.